Skip to main content

CBT for Insomnia
vs
SSRIs for Hot Flashes

A side-by-side comparison of two menopause relief methods — efficacy, cost, how they work, and who shouldn't use them.

Side-by-side comparison

Method
CBT for Insomnia

CBT for Insomnia

A structured talk therapy program that improves sleep during menopause by changing sleep habits and unhelpful thoughts about sleep.

SSRIs for Hot Flashes

SSRIs for Hot Flashes

A low-dose SSRI (paroxetine 7.5 mg) approved by the FDA for moderate-to-severe hot flashes.

EfficacyRecommended see details

Recommended by the Menopause Society for symptom relief.

Recommended see details

Recommended by the Menopause Society for symptom relief.

Cost$0–$200 /per unit

Insurance: Usually

$0–$200 /monthly

Insurance: Usually

Duration6-8 sessions over 8 weeksDaily pill (ongoing)
ReversibilityReversibleReversible
STI ProtectionNoNo
How it works

Cognitive Behavioral Therapy for Insomnia (CBT-I) combines sleep restriction (limiting time in bed to build sleep drive), stimulus control (associating the bed only with sleep), sleep hygiene education, cognitive restructuring (challenging unhelpful beliefs about sleep), and relaxation techniques. It targets the behavioral and cognitive patterns that maintain insomnia, rather than using medication.

Low-dose paroxetine affects serotonin and other neurotransmitters involved in temperature regulation, which can reduce hot flash frequency and severity.

PrescriptionOTC Therapist-delivered (no Rx)Required Prescription required
Available ProductsNo branded products yet1 product
Side effects
  • Temporary daytime sleepiness during initial sleep restriction phase
  • Short-term increase in fatigue as sleep window is narrowed
  • Nausea
  • Headache
  • Fatigue or malaise
Who shouldn't use this
  • Untreated sleep apnea (address apnea first)
  • Active mania or psychosis (CBT-I is not appropriate during acute psychiatric crises)
  • Shift work sleep disorder (CBT-I is designed for chronic insomnia, not circadian rhythm disorders)
  • Current or recent MAOI use (within 14 days)
  • Concomitant thioridazine or pimozide
  • Pregnancy
  • Hypersensitivity to paroxetine or any ingredient